Possible Factors that Influencing the Extant of Infiltration of Immune Cells in Lung Cance
DOI:
https://doi.org/10.61173/dh4qyc40Keywords:
Lung cancer, tumor cell, immune cell, immune cell infiltrationAbstract
Lung cancer has become one of the most common infectious cancers in the world today, causing a large number of deaths every year. Most current research focuses on using PD-1 inhibitors in combination with chemotherapy to treat lung cancer. However, the effect of this treatment plan varies from person to person. It is not effective for patients with low PD-L1 expression, and has the same degree of side effects and poor prognosis. In this article, he systematically introduced the epidemiological knowledge of lung cancer and conducted a comprehensive analysis of the mechanism of tumor cell escape. On this basis, he focused on analyzing the influencing factors of immune cell infiltration (ICI). These influencing factors can provide comprehensive references for subsequent research. In addition, this article conducts a comprehensive comparison of different methods for detecting the degree of infiltration, which can provide a reference for the development of more effective methods in the future.
References
[1] Bade BC, Dela Cruz CS. Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2020 Mar;41(1):1-24.
[2] Puri S, Shafique M. Combination checkpoint inhibitors for treatment of non-small-cell lung cancer: an update on dual anti-CTLA-4 and anti-PD-1/PD-L1 therapies. Drugs Context. 2020;9:2019-9–2.
[3] Huang J, Deng Y, Tin MS, et al. Distribution, Risk Factors, and Temporal Trends for Lung Cancer Incidence and Mortality: A Global Analysis. Chest. 2022 Apr;161(4):1101-1111.
[4] Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011 Feb;6(2):244-85.
[5] Zugazagoitia J, Guedes C, Ponce S, et al. Current Challenges in Cancer Treatment. Clin Ther. 2016 Jul;38(7):1551-66.
[6] Zhou Yonghui, Chen Hongzhi, Li Yan. Research progress of immune checkpoint inhibitors combined with radiotherapy and chemotherapy in the treatment of advanced non-small cell lung cancer. Journal of Clinical Oncology, 2021, 26(10): 947-954.
[7] Wu Q, You L, Nepovimova E, et al. Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape. J Hematol Oncol. 2022 Jun 3;15(1):77.
[8] Chen Jing, Wu Tao, Liu Xuesong. Tumor immunity: the continuous battle between the immune system and tumor cells. Science, 2023, 75(05): 12-16+69.
[9] Lin C, He H, Liu H, et al. Tumour-associated macrophagesderived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer. Gut. 2019 Oct;68(10):1764-1773.
[10] Sobierajska K, Ciszewski WM, Sacewicz-Hofman I, Niewiarowska J. Endothelial Cells in the Tumor Microenvironment. Adv Exp Med Biol. 2020;1234:71-86.
[11] Ren Juan. Interrelationship and mechanism of action between tumor cells and surrounding stromal cells during tumor metastasis and angiogenesis. Shaanxi Province, Xi‘an Jiaotong University, 2009-01-01.
[12] Talmadge JE, Gabrilovich DI. History of myeloid-derived suppressor cells. Nat Rev Cancer, 2013, 13(10): 739-752.
[13] Cui Songkui, Wang Tong. The role of stromal cells in the tumor microenvironment on tumors. Medical Review, 2017, 23(09): 1761-1765.
[14] Zhao Qiwei, Zhou Xinyue, Liu Xiayang, et al. Research progress on the effects of hypoxia-inducible factors on tumor stromal cells. Preventive Medicine, 2024, 36(01): 34-38.
[15] Zhao J, Shi Y, Cao G. The Application of Single-Cell RNA Sequencing in the Inflammatory Tumor Microenvironment. Biomolecules. 2023 Feb 10;13(2):344.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
